Reliability and Validity of DIDA-Q in Parkinson's Disease
Launched by MARMARA UNIVERSITY · Mar 11, 2025
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
Dual task ability is defined as the ability to perform two activities simultaneously . It is known that the ability to perform a motor or cognitive secondary activity at the same time during walking (talking to a person next to you while walking or carrying objects while walking) leads to gait and balance problems of different severity depending on the type of secondary task in Parkinson's Disease (PD). When patients with Parkinson's Disease (pwPD) are exposed to dual-task walking, their walking speed and length of stride decrease, and the frequency of freezing phenomena during walking incr...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with Idiopathic Parkinson's Disease according to UK Brain Bank criteria
- • Walking at least 10 metres without an assistive device
- • To have the cognitive capability to understand and answer the questions asked in the scale
- Exclusion Criteria:
- • Having any neurological disease other than idiopathic Parkinson's Disease
- • The person has an orthopaedic or cardiopulmonary disease that affects walking
- • Severe hearing-visual impairment
About Marmara University
Marmara University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary approach, the university actively engages in the development and evaluation of new therapeutic interventions, fostering collaboration among researchers, clinicians, and industry partners. Marmara University’s focus on ethical standards and patient safety underscores its dedication to contributing valuable insights to the medical community and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, çapa, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported